Jaka jest cena za Mithra Pharmaceuticals S.A. (MITRA)

Cena za Mithra Pharmaceuticals S.A. (MITRA) wynosi $0.25620952

Jaka jest kapitalizacja rynkowa dla Mithra Pharmaceuticals S.A. (MITRA)

Kapitalizacja rynkowa dla Mithra Pharmaceuticals S.A. (MITRA) wynosi $17.14M

Mithra Pharmaceuticals S.A. (MITRA) Wskaźnik C/P

Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège, Belgium, specializes in the creation, production, and worldwide commercialization of advanced therapeutic solutions. The company's core focus areas include contraception, the management of menopause, and treatments for hormone-dependent cancers. Its robust development pipeline features Estelle, a combined oral contraceptive that has successfully concluded Phase III clinical trials, and Donesta, an estetrol-based oral hormone treatment currently undergoing Phase III development for menopausal symptoms. Mithra's product portfolio also encompasses Myring, a hormonal contraceptive vaginal ring; Tibelia, a therapy designed to address both menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant targeting prostate and breast cancers, as well as various benign gynecological conditions. Furthermore, the company markets NEXTSTELLIS, an established oral contraceptive pill. Their offerings span diverse pharmaceutical formats, including polymeric devices, implants, sterile injectable medications, and hormonal tablets.

Rok	Wskaźnik P/S	Zmień
Za mało danych dla podanych dat.

Rok

Wskaźnik P/S

Zmień

Za mało danych dla podanych dat.

Firma	Wskaźnik P/S	Różnica wskaźnika P/S	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	-	IN

Firma

Wskaźnik P/S

Różnica wskaźnika P/S

Kraj